Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/WOCKPHARMA stock hub

NSE/WOCKPHARMA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/WOCKPHARMAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

261B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/WOCKPHARMA

In the news

Latest news · NSE/WOCKPHARMA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E122.6

P25 24.8P50 35.9P75 56.9

ROE4

P25 6.3P50 13.6P75 18.1

ROIC6.5

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/WOCKPHARMA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

220

Groups with data

Currency

INR

Showing 220 of 220 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	2,296
Employees Change	-90%
Employees Change Percent	-3.77
Enterprise value	INR 280.2B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE049B01025
Last refreshed	2026-05-10
Market cap	INR 261B
Price	INR 1,611
Price currency	INR
Rev Per Employee	15,174,216.03x
Sector	Healthcare
Sic	2834
Symbol	nse/WOCKPHARMA
Website	https://www.wockhardt.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.82%
EV Earnings	131.53x
EV/EBIT	54.51x
EV/EBITDA	37.81x
EV/FCF	110.3x
EV/Sales	8.04x
FCF yield	0.97%
P/B ratio	4.94x
P/E ratio	122.63x
P/S ratio	7.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.75%
EBITDA Margin	21.27%
FCF margin	7.29%
Gross margin	67.51%
Gross Profit	INR 23.5B
Gross Profit Growth	28.81%
Gross Profit Growth Q	61.31%
Gross Profit Growth3 Y	16.57%
Gross Profit Growth5 Y	9.44%
Net Income	INR 2.1B
Net Income Growth Quarters	3%
Net Income Growth Years	3%
Net Income Growth5 Y	-20.86%
Pretax Margin	6.83%
Profit Margin	6.11%
Profit Per Employee	INR 927,700
Profitable Years	1
ROA	3.84
Roa5y	0.91
ROCE	7.35
ROE	4
Roe5y	-6.61
ROIC	6.51
Roic5y	1.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	6.57%
Cagr15y	12.21%
Cagr1y	28.7%
Cagr20y	7.81%
Cagr3y	111.41%
Cagr5y	24.99%
Div CAGR10	0%
EPS Growth Quarters	3
EPS Growth Years	3
EPS Growth5 Y	-25.5
FCF Growth3 Y	31.78%
OCF Growth10 Y	18.47%
OCF Growth3 Y	36.6%
Revenue Growth	14.79x
Revenue Growth Q	31.85x
Revenue Growth Quarters	2x
Revenue Growth Years	3x
Revenue Growth3 Y	9.45x
Revenue Growth5 Y	5.17x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 0.42
Assets	INR 86.2B
Cash	INR 6.6B
Current Assets	INR 27B
Current Liabilities	INR 16.2B
Debt	INR 22.3B
Debt EBITDA	INR 3.01
Debt Equity	INR 0.42
Debt FCF	INR 8.79
Equity	INR 52.8B
Interest Coverage	2.41
Liabilities	INR 33.3B
Long Term Assets	INR 59.2B
Long Term Liabilities	INR 17.1B
Net Cash	INR -15.7B
Net Cash By Market Cap	INR -6.02
Net Debt EBITDA	INR 2.12
Net Debt Equity	INR 0.3
Net Debt FCF	INR 6.19
Tangible Book Value	INR 20.6B
Tangible Book Value Per Share	INR 127
WACC	8.44

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.66
Inventory Turnover	1.4
Net Working Capital	INR 10.9B
Quick ratio	0.77
Working Capital	INR 10.8B
Working Capital Turnover	INR 4.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.62%
Dividend per share	INR 0
Last Dividend	INR 10

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	88.97%
1Y total return	28.68%
200-day SMA	1,411.3
3Y total return	845.41%
50-day SMA	1,338.2
50-day SMA vs 200-day SMA	50under200
5Y total return	204.97%
All Time High	2,168.8
All Time High Change	-25.74%
All Time High Date	2013-03-12
All Time Low	66.5
All Time Low Change	2,321.8%
All Time Low Date	2009-04-01
ATR	74.33
Beta	0.77
Beta1y	0.89
Beta2y	0.72
Ch YTD	11.36
High	1,649
High52	1,868.8
High52 Date	2025-06-12
High52ch	-13.82%
Low	1,600.3
Low52	1,086.7
Low52 Date	2026-03-23
Low52ch	48.2%
Ma50ch	20.34%
Price vs 200-day SMA	14.12%
RSI	66.02
RSI Monthly	61.61
RSI Weekly	64.95
Sharpe ratio	0.56x
Sortino ratio	1.23
Total Return	-3.62%
Tr YTD	11.36
Tr15y	462.79%
Tr1m	24.11%
Tr1w	13.02%
Tr3m	15.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 5.1B
Operating Income Growth	153.2
Operating Income Growth Q	283.7
Operating margin	14.75

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	76,490,736%
Net Borrowing	1,410,000,000
Shares Insiders	2.53%
Shares Institutions	14.6%
Shares Out	162,492,169
Shares Qo Q	-0.62%
Shares Yo Y	3.62%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR 2.5B
Average Volume	2,701,914.7x
Bv Per Share	304.4
CAPEX	INR -1.4B
Ch10y	71.79
Ch15y	381.8
Ch1m	24.11
Ch1w	13.02
Ch1y	28.68
Ch20y	263.7
Ch3m	15.17
Ch3y	845.4
Ch5y	181
Ch6m	20.39
Change	-1.65%
Change From Open	-1.67
Close	1,637.5
Days Gap	0.02
Depreciation Amortization	2,270,000,000
Dollar Volume	1,784,992,843.5
Earnings Date	2026-05-04
EBIT	INR 5.1B
EBITDA	INR 7.4B
EPS	INR 13.1
F Score	7
FCF	INR 2.5B
FCF EV Yield	0.91x
FCF Per Share	INR 15.63
Financing CF	-540,000,000
Fiscal Year End	March
Founded	1,967
Goodwill	10,280,000,000
Graham Number	299.55333
Graham Upside	-81.4
Income Tax	INR 390M
Investing CF	-2,410,000,000
Is Primary Listing	1
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Date	2004-04-28
Last Split Type	Forward
Lynch Fair Value	INR 65.5
Lynch Upside	-95.93
Ma150	1,365
Ma150ch	17.98%
Ma20	1,442.9
Ma20ch	11.62%
Net CF	1,050,000,000
Next Earnings Date	2026-08-14
Open	1,637.9
P FCF Ratio	102.8
P OCF Ratio	66.93
Position In Range	20.94
Ppne	22,890,000,000
Price Date	2026-05-08
Price EBITDA	INR 35.23
Ptbv Ratio	12.68
Relative Volume	0.41x
Revenue	34,840,000,000x
SBC By Revenue	0.11x
Share Based Comp	40,000,000
Tax By Revenue	1.12x
Tax Rate	16.39%
Tr20y	349.65%
Tr6m	20.39%
Volume	1,108,347

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/WOCKPHARMA pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/WOCKPHARMA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/WOCKPHARMA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+14.6%

Share of float held by funds and institutions

Insider ownership

+2.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.6%

Negative means the company is buying back shares.

Technical

NSE/WOCKPHARMA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

66.0

Neutral momentum band

Price vs 200-day MA

+14.1%

50/200-day relationship not available

Beta (5Y)

0.77

Less volatile than the market

Sharpe ratio

0.56

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/WOCKPHARMA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/WOCKPHARMA stock rating?

nse/WOCKPHARMA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/WOCKPHARMA analysis?

The full report lives at /stocks/nse/WOCKPHARMA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/WOCKPHARMA?

The latest report frames nse/WOCKPHARMA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/WOCKPHARMA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.